National Foundation for Infectious Diseases Adult Immunization and
... has a negative Hep BsAB should they complete a new hepatitis B (HBV) series and retiter at 4-6 weeks? There are a couple of ways to manage this circumstance which is occurring with increasing frequency as young people who were vaccinated against hepatitis B in infancy now enter the healthcare profes ...
... has a negative Hep BsAB should they complete a new hepatitis B (HBV) series and retiter at 4-6 weeks? There are a couple of ways to manage this circumstance which is occurring with increasing frequency as young people who were vaccinated against hepatitis B in infancy now enter the healthcare profes ...
Vaccines
... • A live or inactivated substance capable of producing an immune response Single constituent,e.g.,, polysaccharide or tetanus, ...
... • A live or inactivated substance capable of producing an immune response Single constituent,e.g.,, polysaccharide or tetanus, ...
Fact Sheet for Menjugate (Meningococcal-C Vaccine)
... IMD often affects previously healthy people of all ages; they can become extremely ill rapidly. IMD can lead to serious infections of the blood (septicaemia), and the covering of the brain and spinal cord (meningitis). How do you get invasive meningococcal disease? The bacteria that cause IMD can li ...
... IMD often affects previously healthy people of all ages; they can become extremely ill rapidly. IMD can lead to serious infections of the blood (septicaemia), and the covering of the brain and spinal cord (meningitis). How do you get invasive meningococcal disease? The bacteria that cause IMD can li ...
Mumps FAQs - SDSU Student Health Services
... most common complication in post-pubertal males. Infection of the nervous system (e.g. meningitis, hearing loss) is possible. Less common complications can involve other organs such as the pancreas, heart, kidneys and ovaries or your joints. In extreme cases, fetal loss can occur during first trimes ...
... most common complication in post-pubertal males. Infection of the nervous system (e.g. meningitis, hearing loss) is possible. Less common complications can involve other organs such as the pancreas, heart, kidneys and ovaries or your joints. In extreme cases, fetal loss can occur during first trimes ...
Chemical Synthesis of Poliovirus cDNA: Generation
... Research on viruses is driven not only by an urgent need to understand, prevent, and cure viral disease. It is also fueled by a strong curiosity about the minute particles that we can view both as chemicals and as “living” entities. Poliovirus can be crystallized (1) and its empirical formula can be ...
... Research on viruses is driven not only by an urgent need to understand, prevent, and cure viral disease. It is also fueled by a strong curiosity about the minute particles that we can view both as chemicals and as “living” entities. Poliovirus can be crystallized (1) and its empirical formula can be ...
تحميل المحاضرة
... Resistance developed in response to stimulus by an antigen (infecting agent or vaccine) and is characterized by the production of antibodies by the host. Passive immunity: Immunity conferred by an antibody produced in another host. It may be acquired naturally or artificially (through an antibody-co ...
... Resistance developed in response to stimulus by an antigen (infecting agent or vaccine) and is characterized by the production of antibodies by the host. Passive immunity: Immunity conferred by an antibody produced in another host. It may be acquired naturally or artificially (through an antibody-co ...
RSV - NSW Health
... Almost all children will have been infected by the age of 3 years, but symptoms are often only mild. Recovery from the illness results in immunity to further infection but this is not long-lasting. ...
... Almost all children will have been infected by the age of 3 years, but symptoms are often only mild. Recovery from the illness results in immunity to further infection but this is not long-lasting. ...
3rd Prize: Omaima Ali
... Smallpox was the first and only human disease to be eradicated; the last case was identified in 1977 when a hospital cook from Somalia4 became infected with a weaker strain of the virus.5 This was 10 years after renewed efforts to eradicate the disease and an increase in funding of US$ 2.4 million i ...
... Smallpox was the first and only human disease to be eradicated; the last case was identified in 1977 when a hospital cook from Somalia4 became infected with a weaker strain of the virus.5 This was 10 years after renewed efforts to eradicate the disease and an increase in funding of US$ 2.4 million i ...
Viral Vaccines - Molecular Immunology
... • They are prepared from extracted cellular fractions e.g. meningococcal vaccine from the polysaccharide antigen of the cell wall, the pneumococcal vaccine from the polysaccharide contained in the capsule of the organism, and hepatitis B polypeptide vaccine. • Their efficacy and safety appear to be ...
... • They are prepared from extracted cellular fractions e.g. meningococcal vaccine from the polysaccharide antigen of the cell wall, the pneumococcal vaccine from the polysaccharide contained in the capsule of the organism, and hepatitis B polypeptide vaccine. • Their efficacy and safety appear to be ...
boostrix - GSK Australia
... sudden sign of allergy such as rash, itching or hives on the skin, swelling of limbs, face, eyes, lips, mouth, throat or other part of the body shortness of breath, breathing or swallowing difficulties unusual tiredness or weakness that is sudden and severe These are signs of an allergic reaction. A ...
... sudden sign of allergy such as rash, itching or hives on the skin, swelling of limbs, face, eyes, lips, mouth, throat or other part of the body shortness of breath, breathing or swallowing difficulties unusual tiredness or weakness that is sudden and severe These are signs of an allergic reaction. A ...
Important Facts Regarding Immunizations
... deadly and preventable diseases. In the U.S., misinformation or lack of information are the main reasons so many children are unprotected. In developing countries, children’s vulnerability to preventable diseases is due to a variety of factors such as underutilization of existing services, unavailab ...
... deadly and preventable diseases. In the U.S., misinformation or lack of information are the main reasons so many children are unprotected. In developing countries, children’s vulnerability to preventable diseases is due to a variety of factors such as underutilization of existing services, unavailab ...
RSV Brochure_final.pmd
... virus for 3–8 days; however, in young infants, the period of infectivity may be as long as 3–4 weeks. ...
... virus for 3–8 days; however, in young infants, the period of infectivity may be as long as 3–4 weeks. ...
VIRUS
... The virus enters the respiratory tract in airborne droplets. Viremia is rare. Virus is present in the nasopharynx from 1-2 days before to 1-2 days after onset of symptoms. Inflammation of the upper respiratory tract causes necrosis of the ciliated and goblet cells of the tracheal and bronchial mucos ...
... The virus enters the respiratory tract in airborne droplets. Viremia is rare. Virus is present in the nasopharynx from 1-2 days before to 1-2 days after onset of symptoms. Inflammation of the upper respiratory tract causes necrosis of the ciliated and goblet cells of the tracheal and bronchial mucos ...
vaccination
... the production of antibodies. The term vaccine derived from Edward Jenner's 1796 use of the cow pox to induce immunity in humans against smallpox. (in Latin vacca means cow) ...
... the production of antibodies. The term vaccine derived from Edward Jenner's 1796 use of the cow pox to induce immunity in humans against smallpox. (in Latin vacca means cow) ...
Slide 1
... Resistance developed in response to stimulus by an antigen (infecting agent or vaccine) and is characterized by the production of antibodies by the host. ...
... Resistance developed in response to stimulus by an antigen (infecting agent or vaccine) and is characterized by the production of antibodies by the host. ...
VACCINE – PREVENTABLE DISEASES
... “Have you ever read the labels?” she asked. “They’re so full of toxins.” Asked if she realized that a shot, had it existed in June, might have saved her client and her baby, she frowned and went back to her clipboard. ...
... “Have you ever read the labels?” she asked. “They’re so full of toxins.” Asked if she realized that a shot, had it existed in June, might have saved her client and her baby, she frowned and went back to her clipboard. ...
Vaccines
... antibody levels high (virus --not infected cells!) • Challenge virus same strain as that used to induce antibody • No vaccine made from one virus strain has protected chimps from another virus strain Protection in man may not result from neutralizing antibodies at all Ability to raise neutralizing a ...
... antibody levels high (virus --not infected cells!) • Challenge virus same strain as that used to induce antibody • No vaccine made from one virus strain has protected chimps from another virus strain Protection in man may not result from neutralizing antibodies at all Ability to raise neutralizing a ...
The Polio Vaccine
... Treatment mainly consists of putting the patient to bed and allowing the affected limbs to be completely relaxed. If breathing is affected, a respirator or iron lung can be used. Physical therapy may be required. 4. Does a polio vaccine exist? In 1947, Jonas Salk, an American physician and microbiol ...
... Treatment mainly consists of putting the patient to bed and allowing the affected limbs to be completely relaxed. If breathing is affected, a respirator or iron lung can be used. Physical therapy may be required. 4. Does a polio vaccine exist? In 1947, Jonas Salk, an American physician and microbiol ...
Immune prophylaxis of infectious diseases in children
... management of immunological answer to prevent the disease between separate persons and groups of the population. ...
... management of immunological answer to prevent the disease between separate persons and groups of the population. ...
The Polio Vaccine - ThinkTwice Global Vaccine Institute
... Treatment mainly consists of putting the patient to bed and allowing the affected limbs to be completely relaxed. If breathing is affected, a respirator or iron lung can be used. Physical therapy may be required. 4. Does a polio vaccine exist? In 1947, Jonas Salk, an American physician and microbiol ...
... Treatment mainly consists of putting the patient to bed and allowing the affected limbs to be completely relaxed. If breathing is affected, a respirator or iron lung can be used. Physical therapy may be required. 4. Does a polio vaccine exist? In 1947, Jonas Salk, an American physician and microbiol ...
powerpoint slides
... Pull: Vaccine Purchase Funds • State and National Governments • International Organizations ...
... Pull: Vaccine Purchase Funds • State and National Governments • International Organizations ...
MMR - Measles, Mumps & Rubella
... Temperature • Fever is usually not higher than 38.5°C (101.5°F). Lymph nodes • Enlarged posterior auricular and suboccipital lymph nodes are usually found on physical examination. Mouth • The Forchheimer sign may still be present on the soft palate. ...
... Temperature • Fever is usually not higher than 38.5°C (101.5°F). Lymph nodes • Enlarged posterior auricular and suboccipital lymph nodes are usually found on physical examination. Mouth • The Forchheimer sign may still be present on the soft palate. ...
What Every Owner Should Know About Vaccines
... coughing and sneezing) in cats. The disease is generally short lived, b ut cats can d evelop chronic symptoms. It is spread through cat-‐to-‐cat contact via eye, n ose and mouth secretions. Infected cats ...
... coughing and sneezing) in cats. The disease is generally short lived, b ut cats can d evelop chronic symptoms. It is spread through cat-‐to-‐cat contact via eye, n ose and mouth secretions. Infected cats ...
boostrix -ipv
... Tell your doctor or nurse as soon as possible if you or your child does not feel or look well during or after having had a dose of BOOSTRIX-IPV vaccine. BOOSTRIX-IPV helps protect most children and adults from diphtheria, tetanus, pertussis and poliovirus infection, but it may have unwanted side eff ...
... Tell your doctor or nurse as soon as possible if you or your child does not feel or look well during or after having had a dose of BOOSTRIX-IPV vaccine. BOOSTRIX-IPV helps protect most children and adults from diphtheria, tetanus, pertussis and poliovirus infection, but it may have unwanted side eff ...
Poliomyelitis
Poliomyelitis, often called polio or infantile paralysis, is an infectious disease caused by the poliovirus. Approximately 90% to 95% of infections cause no symptoms. Another 5 to 10% of people have minor symptoms such as: fever, headache, vomiting, diarrhea, neck stiffness and pains in the arms and legs. These people are usually back to normal within one or two weeks. In about 0.5% of cases there is muscle weakness resulting in an inability to move. This can occur over a few hours to few days. The weakness most often involves the legs but may less commonly involve the muscles of the head, neck and diaphragm. Many but not all people fully recover. In those with muscle weakness about 2% to 5% of children and 15% to 30% of adults die. Years after recovery post-polio syndrome may occur, with a slow development of muscle weakness similar to what the person had during the initial infection.Poliovirus is usually spread from person to person through infected feces entering the mouth. It may also be spread by food or water containing human feces and less commonly from infected saliva. Those who are infected may spread the disease even if no symptoms are present for up to six weeks. The disease may be diagnosed by finding the virus in the feces or detecting antibodies against it in the blood.The disease is preventable with the polio vaccine; however, a number of doses are required for it to be effective. The United States Center for Disease Control recommends polio vaccination boosters for travelers and those who live in countries where the disease is occurring. Once infected there is no specific treatment. In 2013 polio affected 416 people down from 350,000 cases in 1988. In 2014 the disease was only spreading between people in Afghanistan, Nigeria, and Pakistan. In 2015 wild polio was eliminated in Nigeria.Poliomyelitis has existed for thousands of years, with depictions of the disease in ancient art. The disease was first recognized as a distinct condition by Michael Underwood in 1789 and the virus that causes it was first identified in 1908 by Karl Landsteiner. Major outbreaks started to occur in the late 19th century in Europe and the United States. In the 20th century it became one of the most worrying childhood diseases in these areas. The first polio vaccine was developed in the 1950s by Jonas Salk. It is hoped that vaccination efforts and early detection of cases will result in global eradication of the disease by 2018. In 2013; however, there were reports of new cases in Syria and in May 2014, the World Health Organization declared a public health emergency of international concern due to outbreaks of the disease in Asia, Africa and the Middle East. The disease does not naturally occur in any other animals.